Author

Jessalyn Hawkins

Baylor University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Abhinav K. JainiD· 1 shared Aminah J. Tannir· 1 shared Ankan ChoudhuryiD· 1 shared Anurag Majumdar· 1 shared Bidisha ChakrabortyiD· 1 shared Byron Hing Lung LeeiD· 1 shared Colin ScanoiD· 1 shared Deblina Raychaudhuri· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Abhinav K. JainORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Clinical isolates of Fusobacterium nucleatum display strain-specific virulence and modulation by indole derivatives

Colin Scano, Ankan Choudhury, Macarena Rojo, Jessalyn Hawkins, Lauren Crowhurst, Gregory Zaharas, Ramón Lavado, K. Leigh Greathouse

This study identifies strain-specific virulence in Fusobacterium nucleatum and shows indole derivatives reduce invasion and alter junction transcripts in CRC cells.

Microbiology · Jul 10, 2026Peer-reviewedMicrobiology

Loss of KDM6A-mediated genomic instability and metabolic reprogramming differentially regulates responses to immune checkpoint therapy and chemotherapy in bladder cancer.

Pratishtha Singh, Ranit D’Rozario, Bidisha Chakraborty, Swadhin Meher, Deblina Raychaudhuri, Aminah J. Tannir, Yang Li, Anurag Majumdar, Jessalyn Hawkins, Yun zhao Xiong, Philip L. Lorenzi, Padmanee Sharma, Kadir Caner Akdemir, Patrick Glen Pilie, Abhinav K. Jain, , Sangeeta Goswami

This study shows KDM6A mutations in bladder cancer improve response to immune checkpoint therapy but worsen chemotherapy outcomes through effects on DNA repair and metabolic reprogramming.

Nature Communications · Jan 7, 2026Peer-reviewedImmunology